234 related articles for article (PubMed ID: 31221180)
1. Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia.
Duan X; Lian H; Li J; Wu B; Wang W; Wu T; Wang C; Dou Y; Zhou Z; Wang B; Xue L; Wang G
Diagn Pathol; 2019 Jun; 14(1):61. PubMed ID: 31221180
[TBL] [Abstract][Full Text] [Related]
2. Expression of a LINE-1 endonuclease variant in gastric cancer: its association with clinicopathological parameters.
Wang G; Gao J; Huang H; Tian Y; Xue L; Wang W; You W; Lian H; Duan X; Wu B; Wang M
BMC Cancer; 2013 May; 13():265. PubMed ID: 23718141
[TBL] [Abstract][Full Text] [Related]
3. Intestinal metaplasia of the stomach and esophagus: an immunohistochemical study of 60 cases including comparison with normal and inflamed intestinal mucosa.
Chlumská A; Mukenšnabl P; Mareček P; Zámečník M
Cesk Patol; 2014 Jul; 50(3):141-8. PubMed ID: 25186595
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin E and subtypes of intestinal metaplasia in carcinogenesis of the human stomach.
Lin CK; Lai KH; Lo GH; Cheng JS; Hsu PI; Mok KT; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jun; 64(6):331-6. PubMed ID: 11534800
[TBL] [Abstract][Full Text] [Related]
5. bcl-2 protein expression in gastric remnant mucosa and gastric cancer 15 or more years after partial gastrectomy.
Clarke MR; Safatle-Ribeiro AV; Ribeiro U; Sakai P; Reynolds JC
Mod Pathol; 1997 Oct; 10(10):1021-7. PubMed ID: 9346182
[TBL] [Abstract][Full Text] [Related]
6. Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2.
Camilo V; Garrido M; Valente P; Ricardo S; Amaral AL; Barros R; Chaves P; Carneiro F; David L; Almeida R
Histopathology; 2015 Feb; 66(3):343-50. PubMed ID: 25196071
[TBL] [Abstract][Full Text] [Related]
7. [Expression of intestine-specific transcription factor CDX2 in different subtypes of intestinal metaplasia and gastric carcinoma].
Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
Ai Zheng; 2006 Feb; 25(2):185-9. PubMed ID: 16480583
[TBL] [Abstract][Full Text] [Related]
8. Expression of CDX2 and villin in gastric cardiac intestinal metaplasia and the relation with gastric cardiac carcinogenesis.
Xiao ZY; Ru Y; Sun JT; Gao SG; Wang YF; Wang LD; Feng XS
Asian Pac J Cancer Prev; 2012; 13(1):247-50. PubMed ID: 22502678
[TBL] [Abstract][Full Text] [Related]
9. Detection of sulfated glycoproteins in intestinal metaplasia: a comparison of traditional mucin staining with immunohistochemistry for the sulfo-Lewis(a) carbohydrate epitope.
Bodger K; Campbell F; Rhodes JM
J Clin Pathol; 2003 Sep; 56(9):703-8. PubMed ID: 12944557
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte antigen expression in subtypes of intestinal metaplasia of the stomach.
Ocak GA; Yildirim G; Elpek GO
West Indian Med J; 2012 Oct; 61(7):659-64. PubMed ID: 23620961
[TBL] [Abstract][Full Text] [Related]
11. Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea.
Kang KP; Lee HS; Kim N; Kang HM; Park YS; Lee DH; Choe G; Kim JS; Jung HC; Song IS
J Gastroenterol Hepatol; 2009 Jan; 24(1):140-8. PubMed ID: 18713298
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of mucin expression in precancerous tissue of stomach.
Vernygorodskyi S
Exp Oncol; 2013 Jun; 35(2):114-7. PubMed ID: 23828387
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma.
Zheng Y; Wang L; Zhang JP; Yang JY; Zhao ZM; Zhang XY
World J Gastroenterol; 2010 Jan; 16(3):339-44. PubMed ID: 20082479
[TBL] [Abstract][Full Text] [Related]
14. CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia.
Koulis A; Di Costanzo N; Mitchell C; Lade S; Goode D; Busuttil RA; Boussioutas A
BMC Gastroenterol; 2022 Apr; 22(1):197. PubMed ID: 35448971
[TBL] [Abstract][Full Text] [Related]
15. Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion.
Agoston AT; Odze RD
Hum Pathol; 2014 Mar; 45(3):446-55. PubMed ID: 24529328
[TBL] [Abstract][Full Text] [Related]
16. Mucins as key molecules for the classification of intestinal metaplasia of the stomach.
Silva E; Teixeira A; David L; Carneiro F; Reis CA; Sobrinho-Simões J; Serpa J; Veerman E; Bolscher J; Sobrinho-Simões M
Virchows Arch; 2002 Mar; 440(3):311-7. PubMed ID: 11889603
[TBL] [Abstract][Full Text] [Related]
17. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma.
Liu JN; Wang HB; Zhou CC; Hu SY
Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia.
Tsukamoto T; Inada K; Tanaka H; Mizoshita T; Mihara M; Ushijima T; Yamamura Y; Nakamura S; Tatematsu M
J Cancer Res Clin Oncol; 2004 Mar; 130(3):135-45. PubMed ID: 14655050
[TBL] [Abstract][Full Text] [Related]
19. In situ analysis of tissue dynamics and p53 expression in human gastric mucosa.
Imatani A; Sasano H; Yabuki N; Kato K; Ohara S; Asaki S; Toyota T; Nagura H
J Pathol; 1996 May; 179(1):39-42. PubMed ID: 8691342
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of gastric intestinal metaplasia by morphometry in Japanese patients.
Rubio CA; Hirota T; Itabashi M; Hirohashi S; Kato Y
Jpn J Cancer Res; 1992 May; 83(5):495-8. PubMed ID: 1618700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
